"Because there is no reasoned statutory basis for its far-flung reach and misaligned obligations, the disclosure rule is invalid and is hereby set aside," U.S.Alex Azar, HHS secretary, had announced the rule in May 2019, saying that forcing drugmakers to disclose their prices in direct-to-consumer TV advertising could help drive down drug costs if the companies were embarrassed by them.